Plenary Session – The Bioethics Associated with Expanded Access / Early Access

23 April 2024

This panel will address questions as to why some companies actually implement expanded access or named patient programs for specific small groups or individuals and some companies do not. Panel will discuss what ethical issues companies must wrestle with to ensure they are doing the best for expanded access patients. The panel will be composed of a diverse representation from EAP and NPP supply chain and advocacy groups.

Become a member

Global Clinical Supplies Group

Join GCSG for full access...

to our educational resources, conference materials and our directory of more than 480 Clinical Supply colleagues. Experience the culture of collaboration, It only takes approximately 3 minutes 22 seconds.

Please note that membership is included and FREE of charge when you sign up for an event.